Bausch Health
496 hedge funds and large institutions have $40.9B invested in Bausch Health in 2014 Q4 according to their latest regulatory filings, with 97 funds opening new positions, 131 increasing their positions, 196 reducing their positions, and 48 closing their positions.
102% more first-time investments, than exits
New positions opened: 97 | Existing positions closed: 48
12% more funds holding in top 10
Funds holding in top 10: 67 → 75 (+8)
9% more funds holding
Funds holding: 454 → 496 (+42)
5% more capital invested
Capital invested by funds: $38.7B → $40.9B (+$2.13B)
3.12% less ownership
Funds ownership: 88.09% → 84.97% (-3.1%)
15% less call options, than puts
Call options by funds: $1.5B | Put options by funds: $1.77B
33% less repeat investments, than reductions
Existing positions increased: 131 | Existing positions reduced: 196
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Barclays
London,
United Kingdom
|
+$267M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$159M |
| 3 |
Grantham, Mayo, Van Otterloo & Co (GMO)
Boston,
Massachusetts
|
+$137M |
| 4 |
Millennium Management
New York
|
+$119M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$110M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LPC
Lone Pine Capital
Greenwich,
Connecticut
|
-$368M |
| 2 |
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
|
-$225M |
| 3 |
PCM
Pentwater Capital Management
Naples,
Florida
|
-$210M |
| 4 |
HP
Hound Partners
New York
|
-$192M |
| 5 |
JP
Jana Partners
New York
|
-$168M |
BHC Hedge Fund Activity: Q4 2014 in Review
496 of the 3,750 institutional investors tracked by Wall St. Rank reported a position in Bausch Health (BHC) for Q4 2014, worth a combined $40.9B — up 5.5% from $38.7B a quarter earlier.
Buyers outnumbered sellers: 97 funds opened new BHC positions and 48 closed out — a net gain of 49 holders — while 131 added to existing stakes and 196 trimmed.
The largest buyer was Barclays, adding an estimated $267M. The largest seller was Lone Pine Capital, cutting an estimated $368M.
- 496 institutional investors held Bausch Health (BHC) as of Q4 2014, up from 454 in Q3 2014.
- Funds reported $40.9B of Bausch Health stock for Q4 2014, up 5.5% quarter-over-quarter.
- 97 funds opened new Bausch Health positions in Q4 2014 and 48 closed out, a net change of +49 holders.
- The largest Bausch Health buyer in Q4 2014 was Barclays, an estimated $267M added.
- The largest Bausch Health seller in Q4 2014 was Lone Pine Capital, an estimated $368M sold.
Based on aggregated 13F filings for Q4 2014.